{"id":13192,"date":"2023-08-16T10:43:39","date_gmt":"2023-08-16T10:43:39","guid":{"rendered":"https:\/\/www.corp.gruenhorn.de\/?p=13192"},"modified":"2024-07-26T08:46:38","modified_gmt":"2024-07-26T08:46:38","slug":"cannabis-legalisierung-der-patient-fehlt","status":"publish","type":"post","link":"https:\/\/www.gruenhorn.group\/en\/cannabis-legalisierung-der-patient-fehlt\/","title":{"rendered":"Cannabis Legalization: The Patient is Missing"},"content":{"rendered":"<p><b>Gr\u00fcnhorn does not see Improvements for Patients<\/b><\/p>\n<div><b>Gr\u00fcnhorn, the umbrella brand of Germany's largest cannabis network, misses the consideration of cannabis patients in the legalization debate. Even with the upcoming legalization, up to 40% of patient applications are still being rejected by health insurance companies and the Medical Service, which contributes to abuse in the black market.<\/b><\/div>\n<div>The federal cabinet is currently discussing the draft bill for cannabis legalization presented by the Federal Ministry of Health. However, this welcome draft does not consider patients who are in urgent need of medicinal cannabis. According to a survey, up to 40% of all requested applications for medicinal cannabis are still rejected by health insurance companies and the Medical Service.<\/div>\n<div><\/div>\n<div><i>\u00a0\u201cThe legalization is the right step to also reduce prejudices against cannabis in medicine. But patients are not considered at all in the proposed legislation. Alongside legalization, there needs to be education for doctors and health insurance companies. The political realm must address this issue. The educational campaign should not end with adolescents. \u201cFurther studies are needed to generate evidence,<\/i>says Stefan Fritsch, founder of the Gr\u00fcnhorn network. <i>\u201cThe more patients who are able to receive and submit prescriptions, the fewer will be forced to resort to the unregulated black market.\u201d<\/i><\/div>","protected":false},"excerpt":{"rendered":"<p>Gr\u00fcnhorn sieht keine Besserung f\u00fcr Patienten Gr\u00fcnhorn, Dachmarke des gr\u00f6\u00dften deutschen Cannabis-Netzwerks, vermisst in der Legalisierungsdebatte die Ber\u00fccksichtigung der Cannabis-Patienten. Auch mit der kommenden Legalisierung werden nach wie vor bis zu 40 % der Patientenantr\u00e4ge von Krankenkassen und vom Medizinischen Dienst abgelehnt, mit Folgen f\u00fcr den Missbrauch im Schwarzmarkt. Aktuell ber\u00e4t das Bundeskabinett \u00fcber den [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":13722,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","footnotes":""},"categories":[1],"tags":[],"class_list":["post-13192","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pressemeldungen"],"uagb_featured_image_src":{"full":["https:\/\/www.gruenhorn.group\/wp-content\/uploads\/2023\/08\/Cannabis-Legalisierung-Der-Patient-fehlt.webp",1200,601,false],"thumbnail":["https:\/\/www.gruenhorn.group\/wp-content\/uploads\/2023\/08\/Cannabis-Legalisierung-Der-Patient-fehlt-150x150.webp",150,150,true],"medium":["https:\/\/www.gruenhorn.group\/wp-content\/uploads\/2023\/08\/Cannabis-Legalisierung-Der-Patient-fehlt-300x150.webp",300,150,true],"medium_large":["https:\/\/www.gruenhorn.group\/wp-content\/uploads\/2023\/08\/Cannabis-Legalisierung-Der-Patient-fehlt-768x385.webp",768,385,true],"large":["https:\/\/www.gruenhorn.group\/wp-content\/uploads\/2023\/08\/Cannabis-Legalisierung-Der-Patient-fehlt-1024x513.webp",1024,513,true],"1536x1536":["https:\/\/www.gruenhorn.group\/wp-content\/uploads\/2023\/08\/Cannabis-Legalisierung-Der-Patient-fehlt.webp",1200,601,false],"2048x2048":["https:\/\/www.gruenhorn.group\/wp-content\/uploads\/2023\/08\/Cannabis-Legalisierung-Der-Patient-fehlt.webp",1200,601,false],"trp-custom-language-flag":["https:\/\/www.gruenhorn.group\/wp-content\/uploads\/2023\/08\/Cannabis-Legalisierung-Der-Patient-fehlt.webp",18,9,false]},"uagb_author_info":{"display_name":"rsuessenbach","author_link":"https:\/\/www.gruenhorn.group\/en\/author\/rsuessenbach\/"},"uagb_comment_info":0,"uagb_excerpt":"Gr\u00fcnhorn sieht keine Besserung f\u00fcr Patienten Gr\u00fcnhorn, Dachmarke des gr\u00f6\u00dften deutschen Cannabis-Netzwerks, vermisst in der Legalisierungsdebatte die Ber\u00fccksichtigung der Cannabis-Patienten. Auch mit der kommenden Legalisierung werden nach wie vor bis zu 40 % der Patientenantr\u00e4ge von Krankenkassen und vom Medizinischen Dienst abgelehnt, mit Folgen f\u00fcr den Missbrauch im Schwarzmarkt. Aktuell ber\u00e4t das Bundeskabinett \u00fcber den&hellip;","_links":{"self":[{"href":"https:\/\/www.gruenhorn.group\/en\/wp-json\/wp\/v2\/posts\/13192"}],"collection":[{"href":"https:\/\/www.gruenhorn.group\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.gruenhorn.group\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.gruenhorn.group\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.gruenhorn.group\/en\/wp-json\/wp\/v2\/comments?post=13192"}],"version-history":[{"count":2,"href":"https:\/\/www.gruenhorn.group\/en\/wp-json\/wp\/v2\/posts\/13192\/revisions"}],"predecessor-version":[{"id":13723,"href":"https:\/\/www.gruenhorn.group\/en\/wp-json\/wp\/v2\/posts\/13192\/revisions\/13723"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.gruenhorn.group\/en\/wp-json\/wp\/v2\/media\/13722"}],"wp:attachment":[{"href":"https:\/\/www.gruenhorn.group\/en\/wp-json\/wp\/v2\/media?parent=13192"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.gruenhorn.group\/en\/wp-json\/wp\/v2\/categories?post=13192"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.gruenhorn.group\/en\/wp-json\/wp\/v2\/tags?post=13192"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}